Evidence map›Paper›PMID 27069935›Full record

ArticleJournal of immunology research2016

Common Variable Immunodeficiency and Circulating TFH.

Ana Coraglia, Nora Galassi, Diego S Fernández Romero, M Cecilia Juri, Marta Felippo, Alejandro Malbrán, María M E de Bracco

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Significant decreased CXCR3Frontiers in immunology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. A Prevalent CXCR3Journal of clinical immunology · 2020
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ana CoragliaInstituto de Investigaciones Hematológicas (IIHEMA), Academia Nacional de Medicina, C1425ASU Ciudad Autónoma de Buenos Aires, Argentina.
Nora GalassiIMEX-CONICET, Academia Nacional de Medicina, C1425ASU Ciudad Autónoma de Buenos Aires, Argentina.
Diego S Fernández RomeroUnidad de Alergia, Asma e Inmunología Clínica, C1035AAT Ciudad Autónoma de Buenos Aires, Argentina.
M Cecilia JuriUnidad de Alergia, Asma e Inmunología Clínica, C1035AAT Ciudad Autónoma de Buenos Aires, Argentina.
Marta FelippoIMEX-CONICET, Academia Nacional de Medicina, C1425ASU Ciudad Autónoma de Buenos Aires, Argentina.
Alejandro MalbránUnidad de Alergia, Asma e Inmunología Clínica, C1035AAT Ciudad Autónoma de Buenos Aires, Argentina.
María M E de BraccoInstituto de Investigaciones Hematológicas (IIHEMA), Academia Nacional de Medicina, C1425ASU Ciudad Autónoma de Buenos Aires, Argentina; IMEX-CONICET, Academia Nacional de Medicina, C1425ASU Ciudad Autónoma de Buenos Aires, Argentina.
Academia Nacional de Medicina · ARHospital Alemán · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD4+ T follicular helper cells (TFH) were assessed in adult patients with common variable immune deficiency (CVID) classified according to the presence of granulomatous disease (GD), autoimmunity (AI), or both GD and AI (Group I) or the absence of AI and GD (Group II). TFH lymphocytes were characterized by expression of CXCR5 and PD-1. TFH were higher (in both absolute number and percentage) in Group I than in Group II CVID patients and normal controls (N). Within CXCR5+CD4+ T cells, the percentage of PD-1 (+) was higher and that of CCR7 (+) was lower in Group I than in Group II and N. The percentages of Treg and TFH reg were similar in both CVID groups and in N. TFH responded to stimulation increasing the expression of the costimulatory molecules CD40L and ICOS as did N. After submitogenic PHA+IL-2 stimulation, intracellular expression of TFH cytokines (IL-10, IL-21) was higher than N in Group I, and IL-4 was higher than N in Group II. These results suggest that TFH are functional in CVID and highlight the association of increased circulating TFH with AI and GD manifestations.

Indexed as

AdultAgedAutoimmunityCase-Control StudiesCD40 LigandCommon Variable ImmunodeficiencyFemaleGene Expression RegulationGranulomatous Disease, ChronicHumansInducible T-Cell Co-Stimulator ProteinInterleukin-10Interleukin-2Interleukin-21Interleukin-4InterleukinsCCR7 protein, humanCD40 LigandCXCR5 protein, humanICOS protein, humanIL10 protein, humanIL4 protein, humanInducible T-Cell Co-Stimulator ProteinInterleukin-10Interleukin-2Interleukin-21Interleukin-4InterleukinsPDCD1 protein, humanPhytohemagglutininsProgrammed Cell Death 1 ReceptorReceptors, CCR7Receptors, CXCR5

Identifiers

PMID27069935
PMCPMC4812460
OpenAlexW2299476145

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.